Přihlásit se Zaregistrujte se zdarma

1letý cíl společnosti Æterna Zentaris

Jaká je hodnota metriky 1letý cíl společnosti Æterna Zentaris?

Hodnota metriky 1letý cíl společnosti Æterna Zentaris, Inc. je CAD$5 -36.72%

Jaká je definice metriky 1letý cíl?

1-letý cíl (1-year target) je analytiky předpokládaná cena akcie za rok od dnešního dne.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

1letý cíl společností v sektoru Health Care sektor na TSX ve srovnání se společností Æterna Zentaris

Čemu se věnuje společnost Æterna Zentaris?

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

Firmy s metrikou 1letý cíl podobnou společnosti Æterna Zentaris



  • Hodnota metriky 1letý cíl společnosti SJM je HKD$4 +70.39%
  • Hodnota metriky 1letý cíl společnosti Aurizon je AUD$4 +16.03%
  • Hodnota metriky 1letý cíl společnosti Domain Australia je AUD$4 +40.14%
  • Hodnota metriky 1letý cíl společnosti Technovator International je HKD$5 +1,676.05%
  • Hodnota metriky 1letý cíl společnosti Canada Nickel je CAD$4 +282.69%
  • Hodnota metriky 1letý cíl společnosti Beter Bed N.V je €4 -33.44%
  • Hodnota metriky 1letý cíl společnosti Æterna Zentaris je CAD$5 -36.72%
  • Hodnota metriky 1letý cíl společnosti Fullshare je HKD$5 +1,124.35%
  • Hodnota metriky 1letý cíl společnosti Volex plc je GBX327 -2.65%
  • Hodnota metriky 1letý cíl společnosti Stockland Stapled Securities je AUD$4 -23.47%
  • Hodnota metriky 1letý cíl společnosti Beijing Capital Land je HKD$5 +67.36%
  • Hodnota metriky 1letý cíl společnosti Gogold Resources je CAD$5 +366.53%
  • Hodnota metriky 1letý cíl společnosti Kneat.Com Inc je CAD$4 -15.55%